Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02563860 · ClinicalTrials.gov registry record · Phase 2
Pharmacological Treatment of Rett Syndrome With Statins
A Phase 2 study, sponsored by Montefiore Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 20
- Enrollment target
NCT02563860: Completed Phase 2 study, sponsored by Montefiore Medical Center.
NCT02563860 is a Phase 2 study that has completed, run by Montefiore Medical Center. The registered enrollment target is 20 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02563860, a Phase 2 study, has completed, sponsored by Montefiore Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 20 participants
- Enrollment target
Study Summary
This is a phase 2 , open label, dose escalating study of Lovastatin in Rett syndrome.
Primary Outcome
To perform quantitative gait assessment using a computerized walkway with embedded pressure sendors (GAIT rite)
Interventions
- DRUG Lovastatin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2015-07 |
| Est. Completion | 2016-07 |
| Phase | Phase 2 |
What the finished NCT02563860 record still lists
NCT02563860 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (85% lower).
The record links to 0 conditions, and to 1 intervention - of which Lovastatin is the first listed.
NCT02563860 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02563860 about?
NCT02563860 is a clinical study titled "Pharmacological Treatment of Rett Syndrome With Statins". This is a phase 2 , open label, dose escalating study of Lovastatin in Rett syndrome.
What is the current status of trial NCT02563860?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2015-07. Estimated completion is 2016-07.
What interventions are being tested in trial NCT02563860?
The interventions under investigation include: Lovastatin (DRUG).
Who is sponsoring clinical trial NCT02563860?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02563860's enrollment target sits among peer trials
20 1805th of 2000 higher than 107 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia